Literature DB >> 31202286

Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection.

Narissa Williams1, Nicholas Bossert1, Yang Chen2, Urmo Jaanimägi1, Marianthi Markatou3, Andrew H Talal4.   

Abstract

BACKGROUND: Social determinants of health (SDOH), i.e., social, behavioral and environmental factors, are increasingly recognized for their important influence on health outcomes. Data are limited on the influence of SDOH, substance use characteristics, and their interactions on pursuit of hepatitis C virus (HCV) care among individuals with opioid use disorder (OUD). Linkage to HCV care remains low in this population despite high HCV prevalence and incidence. AIMS: To investigate the influence of SDOH, substance use factors, and their interactions on HCV treatment uptake among OUD patients in a methadone treatment program.
METHODS: Information on patient demographics, SDOH, substance use characteristics, and co-morbid medical conditions were obtained from the paper and electronic medical records of OUD patients on methadone. We applied multiple correspondence analysis, k-means algorithm, and logistic regression with least absolute shrinkage and selection operator penalty to identify variables and clusters associated with pursuit of HCV care.
RESULTS: Data from 161 patients (57% male, 60% Caucasian, mean age 45 years) were evaluated. Being employed, the absence of support systems, and a history of foster care were the strongest positive predictors of treatment pursuit. The use of crack/cocaine as the initial illicit substance, criminal activity without incarceration, and the absence of a family history of chemical dependency were the strongest negative predictors. We identified clusters among persons with OUD based upon their likelihood to pursue HCV management.
CONCLUSION: Utilizing data from the medical record, we were able to identify factors positively and negatively associated with linkage-to-care for HCV. We were also able to divide patients into clusters of factors associated with linkage-to-care for HCV. These results could be used to identify individuals with OUD based upon their readiness for HCV care.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Communicable diseases; Hepatitis; Social determinants of health; Substance-related disorders; Therapeutics; Treatment adherence and compliance

Mesh:

Substances:

Year:  2019        PMID: 31202286     DOI: 10.1016/j.jsat.2019.04.009

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  3 in total

1.  Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.

Authors:  Denis Ouzan; Dominique Larrey; Dominique Guyader; André-Jean Remy; Ghassan Riachi; Fréderic Heluwaert; Régine Truchi; Jean-Marc Combis; François Bailly; Isabelle Rosa; Christophe Hézode; Denise Glorian-Petraud; Olivier Libert; Heribert Ramroth; Tarik Asselah; Gérard Thiefin; Dominique Roulot; Bruno Roche; Vincent Leroy; Jérôme Dumortier; Dominique Thabut; Stanislas Pol
Journal:  Dig Dis Sci       Date:  2020-04-18       Impact factor: 3.199

2.  The Rise of Prescription Digital Therapeutics in Behavioral Health.

Authors:  Christina A Brezing; Diana I Brixner
Journal:  Adv Ther       Date:  2022-10-15       Impact factor: 4.070

3.  Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.

Authors:  Noor Taweh; Esther Schlossberg; Cynthia Frank; Ank Nijhawan; Irene Kuo; Kevin Knight; Sandra A Springer
Journal:  Int J Drug Policy       Date:  2021-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.